Tysabri Lawsuit

July 28, 2011

Patients or loved ones of those who have been prescribed Tysabri and have developed Progressive Multifocal Leukoencephalopathy (PML) have the right to pursue a Tysabri Lawsuit in order to seek compensation for the injuries caused by Tysabri. The Willis law firm can help you file your Tysabri lawsuit.

A Tysabri lawsuit is filed to hold the makers of Tysabri, Biogen Idec and Élan responsible for the horrible and life changing injuries that may have been caused by their drug, Tysabri. Tysabri lawsuits claim that severe and detrimental health problems and or deaths occurred due to taking Tysabri as a treatment of multiple sclerosis (MS) or Crohn’s.

About Tysabri

Tysabri is a drug marketed by both Biogen Idec and Élan. Tysabri is primarily used to treat multiple sclerosis (MS) and Crohn’s disease. Administered by intravenous injection, Tysabri is injected approximately once every 28 days. Initially approved in 2004 by the FDA, Tysabri was subsequently withdrawn by the manufacturer after Tysabri was linked with multiple cases of progressive multifocal leukoencephalopathy (PML). Tysabri was reintroduced into the market in 2006, and cases of progressive multifocal leukoencephalopathy (PML) have been on the rise ever since.

Tysabri has been very effective at treating some patients for multiple sclerosis (MS), even causing a full remission of the disease, but patients taking Tysabri may be at risk of developing progressive multifocal leukoencephalopathy (PML) which can be more severe and life-threatening than MS. Currently, Tysabri’s packaging states that about 1.16 of every 1000 patients taking Tysabri will develop progressive multifocal leukoencephalopathy (PML). Approximately 80% of MS or Crohn’s patients taking Tysabri who are diagnosed with PML will die within six months of their PML diagnosis. Progressive multifocal leukoencephalopathy (PML) is the main topic of the Tysabri lawsuits.

At current time, there is no known cure for the development of progressive multifocal leukoencephalopathy (PML). It is a commonly found virus, approximately 80-90% of humans carry the virus in a latent form. It can flare and become dangerous when the immune system is down or through the use of drugs such as Tysabri. PML is more common among patients suffering from AIDS because of their weak immune systems. However, through aggressive immunotherapy treatment, approximately half of AIDS-PML patients may live. This number is higher than the survival rate of PML patients who took Tysabri.

Tysabri Lawsuit: Contact a Lawyer

If you or a loved one took Biogen Idec and Élan’s drug Tysabri to treat multiple sclerosis (MS) or Crohn’s disease and have developed progressive multifocal leukoencephalopathy (PML) please call and talk to a Tysabri lawyer today. Our lawyers are standing by, ready to investigate at no charge your potential Tysabri Lawsuit.

We encourage you to learn more about your legal options in pursuing a Tysabri Lawsuit against the makers of the dangerous drug. Contact the Willis Law Firm for a risk-free consultation about your potential Tysabri Lawsuit. You may be entitled to compensation for injuries sustained by Tysabri. All cases are handled on a Contingency Fee basis (no attorney fees or expenses charged unless we recover for you). Call us Toll Free at 1-800-883-9858

© Willis Law Firm for Drug Attorneys. Replication strictly prohibited without written consent.